Medicine is changing with two major revolutions: Genomic Medicine and Cellular Therapies. Genomic revolution in Medicine has created greatest possibilities for prevention and cure of chronic diseases. Our increasing knowledge on the genetic mechanisms reveals that not only the diseases inherited from the parents but all diseases are "genetic" said Prof. Dr. Ender Altiok, Managing Director of GENETIKA. Prof. Dr. Altiok will participate to speak at the 2nd Inherited Haemolytic Anaemia Update Course and Workshops on 4^th of May 2009 in King Abdulaziz University, Jeddah / Saudi Arabia, which is organized by Saudi Haematology Society.

GENETIKA is Acibadem Healthcare Group's Genetic Diagnosis Center and Treatment Center, the largest genetic center in Turkey and one of the largest genetic laboratories in Europe by 250 different genetic tests done by using modern genetic testing methods including more than 20,000 diagnostic DNA sequencing every year. GENETIKA provides well equipped and modern facilities for the diagnosis and prevention of human genetic disorders. GENETIKA gives genetic service to all around the world including United States, Canada, Denmark, India, Egypt, Saudi Arabia, Syria, Spain, South Africa, Romania, Azerbaydcan. Some genetic tests in the world are done only by a few laboratories including Acibadem ( for example: griscelli, osteopetrosis, osteoimperfecta genetic tests). GENETIKA is member of EMQN (European Molecular Genetics Quality Network) and is listed in official sites of NIH ( National Institutes of Health)( www.geneclinics.org),  EDDNAL, Eurogentest ( EU official). GENETIKA is the  first and currently only Cell Processing laboratory in JACIE (Joint Accredidation Committee of International Society Cell Therapy  and European Bone Marrow Transplantation Society) accreditation process in the Eastern Europe and Middle East.

The genetic casualty can be one step or in multi steps.  The treatment and rehabilitation for these increasing numbers of diseases require high financial and human sources thus imposing enormous burden on the healthcare system.  Molecular medicine lead by molecular genetics could contribute to the prevention of genetic conditions and to reduction of the healthcare costs. Genetic counselling followed by carrier testing and prenatal testing for genetic disorders are effective ways to prevent such disorders. In recent years pre-implantation genetic diagnosis (PGD) is also possible. With PGD, before any pregnancy, the embryos are obtained from the couples and selected against disease in the family and transferred to the candidate mother. If pregnancy occurs, the baby has the maximum chance to be normal. In this way termination of the pregnancy can be avoided.

Medicine is also heading for the age of cellular therapies. Cellular therapies offer the chance of transplanting a living source for regeneration of organs.  The diseases that could not be prevented may be treated by transplantation of normal cells. A genetic condition can be treated with normal cells from a donor. For example thalassemias and more than 40 conditions have been treated with stem cells for more than 35 years. The stringent requirements for stem cell therapies are stem cell sources like bone marrow and cord blood. Because of this reason stem cell banking is crucial.  In recent years cellular therapies have   been being developed for conditions like Multiple sclerosis, urea cycle defects and even for anti aging therapy.  Embryonic stem cell banking and embryonic stem cell based therapies may carry  therapeutic achievements further ahead if  technical, ethical and legal regulations can be done.

GENETIKA incubates a Cell Processing Laboratory and Stem Cell Banking Units at cGMP (Good Manufacturing Practice) standards. The laboratory process and stores stem cells from a variety of sources including cord blood, peripheral blood and bone marrow from transplantation purposes as well as for other cell therapies. The laboratory has processed close to 5000 units of cord blood and  hundreds of  units of PBSC ( peripheral blood stem cells)  for both autologous and allogenic transplantation purposes.  

 - Ends -


About GENETIKA
GENETIKA  is Acibadem's Genetic Diagnosis Center, the largest genetic center in Turkey and one of the largest genetic laboratories in Europe by  250 different genetic tests done by using modern genetic testing methods including  more than 20,000 diagnostic DNA sequencing every year. GENETIKA provides well equipped and modern facilities for the diagnosis and prevention of human genetic disorders. The services offered include genetic counselling, cytogenetic, molecular cytogenetic, molecular testing for prenatal, postnatal and preimplantation genetic diagnosis. Discovery of genetic defects as well as prenatal and embryo genetic testing is done for a variety of diseases including infertility, miscarriage, HLA matching,  beta thalassemia, cystic fibrosis, familial mediterranean fever, fragile-X,  Duchenne and Becker muscular dystrophy, Charcot-Marie-Tooth disease, spinocerebellar ataxias, hemophilia A, hemophilia B,  myotonic dystrophy, thrombosis risk,spinal muscular atrophy, phenylketonuria, alzheimer, breast cancer, colon cancers, medullary thyroid cGENETIKA  is Acibadem's Genetic Diagnosis Center, the largest genetic center in Turkey and one of the largest genetic laboratories in Europe by  250 different genetic tests done by using modern genetic testing methods including  more than 20,000 diagnostic DNA sequencing every year. GENETIKA provides well equipped and modern facilities for the diagnosis and prevention of human genetic disorders. The services offered include genetic counselling, cytogenetic, molecular cytogenetic, molecular testing for prenatal, postnatal and preimplantation genetic diagnosis. Discovery of genetic defects as well as prenatal and embryo genetic testing is done for a variety of diseases including infertility, miscarriage, HLA matching,  beta thalassemia, cystic fibrosis, familial mediterranean fever, fragile-X,  Duchenne and Becker muscular dystrophy, Charcot-Marie-Tooth disease, spinocerebellar ataxias, hemophilia A, hemophilia B,  myotonic dystrophy, thrombosis riskancer, ovarian cancer, melanoma, leukemias, immunodeficiencies, microbiology PCR tests for HPV, HBV, HCV, and tuberculosis.are some of the conditions  that genetic counselling and testing are available. Whole list of tests can be found at the atached catalog or at www.acibademgenetik.com.

About Acibadem Healthcare Group
Ac?badem Healthcare Group, the leading private healthcare services provider of Turkey, has nearly 8,500 employees, including 1,800 physicians. The group, expanding its healthcare chain continuously, is present in 21 different locations through a network of 9 general hospitals, 8 medical centers, a central laboratory, central pathology laboratory and a specialized ophthalmology center.

Ac?badem Healthcare Group Hospitals and medical centers accredited by Joint Commission International (JCI) and represented as a model for quality in healthcare for the region. Ac?badem Healthcare Group is the only healthcare chain which is accredited as a "system" by Joint Commission International in the Middle East region.

Ac?badem, with its current investments and modern medical technology has a total of 58 operating rooms and a 1115 bed capacity.

Website: www.acibadem.com.tr/English    

Fore more information, please contact to:
Dr. Fatih Mehmet GUL
Business Development Manager
Acibadem Healthcare Group
Middle East / North Africa
M: fmgul@acibadem.com.tr  

© Press Release 2009

 

Community Comments (0) - Comment on this article

The opinions of the authors expressed herein do not necessarily state or reflect Zawya. Read our Comment Policy.

 

 

 

close x

Loading ...

 

close x

Report Abuse

Loading ...

 

 

close x

Loading ...